• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用马昔腾坦治疗肺动脉高压后出现的棉絮状渗出斑

COTTON-WOOL SPOTS AFTER USE OF MACITENTAN FOR PULMONARY ARTERIAL HYPERTENSION.

作者信息

Khan Mohammed Ali, Ho Allen C, Spirn Marc J

机构信息

Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania.

出版信息

Retin Cases Brief Rep. 2017;11(1):4-6. doi: 10.1097/ICB.0000000000000273.

DOI:10.1097/ICB.0000000000000273
PMID:26829448
Abstract

PURPOSE

To report a case of transient, bilateral cotton spots after initiation of macitentan, an endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension.

METHODS

Case report.

RESULTS

A 76-year-old woman with WHO Class IIIb pulmonary arterial hypertension was referred for evaluation of bilateral cotton-wool spots 1 week after starting macitentan therapy. The patient was asymptomatic and visual acuity was 20/25 in each eye. Fluorescein angiography and optical coherence tomography were completed. Given lack of symptoms and alternative treatment options, the patient was observed closely. The cotton-wool spots resolved 8 weeks after presentation and visual acuity remained stable at 20/25. Throughout the observation period, average mean arterial pressure was within normal limits at 84.8.

CONCLUSION

In patients using endothelin receptor antagonists, medication side effect should be considered in the differential diagnosis of cotton-wool spots.

摘要

目的

报告1例在开始使用马西替坦(一种用于治疗肺动脉高压的内皮素受体拮抗剂)后出现短暂双侧棉絮斑的病例。

方法

病例报告。

结果

一名76岁、世界卫生组织功能分级为IIIb级的肺动脉高压女性患者,在开始马西替坦治疗1周后因双侧棉絮斑接受评估。患者无症状,每只眼视力均为20/25。完成了荧光素血管造影和光学相干断层扫描。鉴于患者无症状且有其他治疗选择,对其进行密切观察。棉絮斑在出现后8周消退,视力保持稳定,仍为20/25。在整个观察期内,平均动脉压正常,为84.8。

结论

在使用内皮素受体拮抗剂的患者中,棉絮斑的鉴别诊断应考虑药物副作用。

相似文献

1
COTTON-WOOL SPOTS AFTER USE OF MACITENTAN FOR PULMONARY ARTERIAL HYPERTENSION.使用马昔腾坦治疗肺动脉高压后出现的棉絮状渗出斑
Retin Cases Brief Rep. 2017;11(1):4-6. doi: 10.1097/ICB.0000000000000273.
2
Bilateral cotton wool spots after use of an endothelin receptor antagonist.使用内皮素受体拮抗剂后出现双侧棉絮状渗出斑。
Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):156-9. doi: 10.3928/23258160-20140124-01. Epub 2014 Jan 23.
3
Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertension.在开始使用马昔腾坦治疗肺动脉高压后,呼吸困难严重恶化。
Int J Cardiol. 2016 Jan 1;202:244-5. doi: 10.1016/j.ijcard.2015.08.132. Epub 2015 Sep 14.
4
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.马昔腾坦治疗肺动脉高压的安全性、有效性及临床应用价值
Drug Des Devel Ther. 2016 May 18;10:1675-82. doi: 10.2147/DDDT.S88612. eCollection 2016.
5
Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan.内皮素-1受体拮抗剂换用马昔腾坦后的肺动脉高压结局
J Int Med Res. 2019 May;47(5):2177-2186. doi: 10.1177/0300060519840130. Epub 2019 Apr 12.
6
Macitentan and morbidity and mortality in pulmonary arterial hypertension.马西替坦治疗肺动脉高压的发病率和死亡率。
N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.
7
Macitentan for the treatment of pulmonary arterial hypertension.马昔腾坦用于治疗肺动脉高压。
Drugs Today (Barc). 2014 Jun;50(6):401-6. doi: 10.1358/dot.2014.50.6.2146837.
8
Serious Liver Injury Associated with Macitentan: A Case Report.麦格司他坦相关严重肝损伤:1 例报告。
Pharmacotherapy. 2018 Feb;38(2):e22-e24. doi: 10.1002/phar.2078. Epub 2018 Jan 30.
9
Pharmacokinetic and pharmacodynamic evaluation of macitentan , a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.马昔腾坦(一种用于治疗肺动脉高压的新型内皮素受体拮抗剂)的药代动力学和药效学评价
Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):437-49. doi: 10.1517/17425255.2015.1000859. Epub 2015 Jan 21.
10
[The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension].新型内皮素受体拮抗剂马昔腾坦:肺动脉高压的治疗前景
Ter Arkh. 2016;88(7):89-97. doi: 10.17116/terarkh201688789-97.

引用本文的文献

1
A case study of ciliary detachment with primary pulmonary hypertension.
Int Ophthalmol. 2018 Feb;38(1):375-379. doi: 10.1007/s10792-017-0443-4. Epub 2017 Jan 21.